Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction.

ABSTRACT:

SUBMITTER: Fu W 

PROVIDER: S-EPMC7673315 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature